Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung CancerRiichiroh Maruyama, Masahiro Fukuoka, Masahiro Tsuboi et al.|Journal of Clinical Oncology|2008Cited by 365
Usefulness of ultrathin bronchoscopy in diagnosis of lung cancerSuguru Yamamoto, Yoko Kusunoki, Kiyonobu Ueno et al.|Lung Cancer|2004Cited by 58
Early responses of <i>EGFR</i> circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatmentFumio Imamura, Kikuya Kato|Oncotarget|2016Cited by 22
Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patientsKikuya Kato, Fumio Imamura|Scientific Reports|2016Cited by 17
Transient appearance of circulating tumor DNA associated with de novo treatmentKikuya Kato, Fumio Imamura|Scientific Reports|2016Cited by 13